1-2 of 2
Rosa Filiberti, BS
Close
Sort by
Journal Articles

Higher Versus Standard Doses of Recombinant Erythropoietin for the Treatment of Anemia in Patients with Myelodysplastic Syndromes: Results of a Retrospective Survey from the Italian Registry of Myelodisplastic Syndromes (FISM)

Enrico Balleari, MD, Rosa Filiberti, BS, Chiara Salvetti, MD, Bernardino Allione, MD, Emanuele Angelucci, MD, Tullio Calzamiglia, MD, Marina Cavaliere, MD, Daniela Cilloni, MD, Marino Clavio, MD, Anna Da Col, MD, Paolo Danise, Anna Angela Di Tucci, Dario Ferrero, Carlo Finelli, MD, Daniela Gioia, MD, Roberto M Lemoli, MD, Alessandro Levis, Emanuela Messa, Elisa Masera, Maurizio Miglino, PhD, Pellegrino Musto, Esther Natalie Oliva, MD, Antonella Poloni, MD, Marco Scudeletti, MD, Rodolfo Tassara, MD, Valeria Santini, MD
Journal: Blood
Blood (2016) 128 (22): 4342.
https://doi.org/10.1182/blood.V128.22.4342.4342
Published: 2016
Journal Articles

The Impact of Comorbidities on Clinical Outcome of Patients with Myelodysplastic Syndromes: A Real-Life Survey

Enrico Balleari, MD, Chiara Salvetti, MD, Andrea Bacigalupo, MD, Gianluca Forni, MD, Marco Gobbi, MD, Riccardo Ghio, PhD MD, Marco Scudeletti, MD, Rodolfo Tassara, MD, Giovanni Berisso, MD, Tullio Calzamiglia, MD, Eleonora Arboscello, MD, Germana Beltrami, MD, Micaela Bergamaschi, MD, Maurizio Cavalleri, MD, Lisette Del Corso, MD, Serena Favorini, MD, Rosa Filiberti, BS, Riccardo Goretti, MD, Maurizio Miglino, PhD, Laura Mitschoning, MD, Elisa Molinari, MD, Omar Racchi, MD, Marino Clavio, MD
Journal: Blood
Blood (2014) 124 (21): 4668.
https://doi.org/10.1182/blood.V124.21.4668.4668
Published: 2014